Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Cotadutide Given by Subcutaneous Injection in Adult Participants With Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis [Phase 2]

View source ↗

Summary

This clinical trial update reports results from a Phase 2 study evaluating the safety and efficacy of cotadutide given by subcutaneous injection in adults with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease
• Nonalcoholic Steatohepatitis

Drugs mentioned

• Cotadutide (cotadutide)

Snippet

Sponsor: AstraZeneca | Conditions: Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis | Phase 2 | Status: COMPLETED | Results posted: 2025-09-03